Fresenius SE & Co. KGaA
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments:...
Latest News
1 month ago · zacks.com
Are Investors Undervaluing Fresenius SE & Co. (FSNUY) Right Now?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
1 month ago · prnewswire.com
Waltz Health and Fresenius Kabi Expand Direct Access to Biosimilars Through Waltz Connect PlatformCollaboration provides direct access to three competitively priced biosimilars through a transparent pricing model across immunology and inflammatory diseases CHICAGO and LAKE ZURICH, Ill, Sept. 29, 2026 /PRNewswire/ -- Waltz Health®, an EVERSANA® company developing technologies and services that support better-informed decisions on prescription care and Fresenius Kabi®, an operating company of Fresenius, and a leading provider of essential medicines and medical technologies, today announced an agreement to provide employers, payers and pharmacy benefit managers (PBMs) with direct access to three competitively priced biosimilars.
2 months ago · zacks.com
Should Value Investors Buy Fresenius SE & Co. (FSNUY) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Add to Watchlist
Select watchlists to add or remove FSNUY